MYC on the Path to Cancer

Cited by (1,009)

Items 401–500 of 1,009

1. Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells
   Dang Wu, Wanyan Wang, Wuyan Chen, Fulin Lian, Li Lang, Ying Huang, Yechun Xu, Naixia Zhang, Yinbin Chen, Mingyao Liu et al. · 2018 · Haematologica
2. An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
   Mélanie Mahé, Florent Dufour, Hélène Neyret‐Kahn, Aura Ileana Moreno-Vega, C Béraud, Mingjun Shi, Imène Hamaidi, Virginia Sánchez‐Quiles, Clémentine Krucker, Marion Dorland‐Galliot et al. · 2018 · EMBO Molecular Medicine
3. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA–mRNA interactions
   Hyun Min Jung, Rushi S. Patel, Brittany Lynn Phillips, Hai Wang, Donald M. Cohen, William C. Reinhold, Lung‐Ji Chang, Lijun Yang, Edward K. L. Chan · 2013 · Molecular Biology of the Cell
4. A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis
   Han Han, Dan Sun, Wenjuan Li, Hongxing Shen, Yahui Zhu, Chen Li, Yuxing Chen, Long-Feng Lu, Wenhua Li, Jinxiang Zhang et al. · 2013 · Hepatology
5. Metabolic Plasticity of Tumor Cell Mitochondria
   Giuseppe Cannino, Francesco Ciscato, Ionica Masgras, Carlos Sànchez‐Martìn, Andrea Rasola · 2018 · Frontiers in Oncology
6. Genetic requirement forMycland efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer
   Dong Wook Kim, Nan Wu, Young‐Chul Kim, Pei Feng Cheng, Ryan Basom, Dongkyoon Kim, Colin T. Dunn, Anastasia Y. Lee, Kee‐Beom Kim, Chang Sup Lee et al. · 2016 · Genes & Development
7. Inference of transcriptional regulation in cancers
   Peng Jiang, Matthew L. Freedman, Jun S. Liu, Xiaole Shirley Liu · 2015 · Proceedings of the National Academy of Sciences
8. Why should cancer biologists care about tRNAs? tRNA synthesis, mRNA translation and the control of growth
   Savraj Grewal · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
9. Keeping ribosomal DNA intact: a repeating challenge
   Daniël O. Warmerdam, Rob M.F. Wolthuis · 2018 · Chromosome Research
10. The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35
    Pei Yan Liu, Andrew E. Tee, Giorgio Milazzo, Katherine M. Hannan, Jesper L.V. Mååg, Sujanna Mondal, Bernard Atmadibrata, Nenad Bartoniček, Hui Peng, Nicholas Ho et al. · 2019 · Nature Communications
11. MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc–Mediated Cell-Cycle Progression and Proliferation in Lung Cancer
    Qingqing Zhu, Chongguo Zhang, Tianyu Qu, Xiyi Lu, Xuezhi He, Wei Li, Dandan Yin, Liang Han, Renhua Guo, Erbao Zhang · 2022 · Cancer Research
12. Altered glutamine metabolism in platinum resistant ovarian cancer
    Chantelle D. Hudson, Alyssa Savadelis, Anil Belur Nagaraj, Peronne L. Joseph, Stefanie Avril, Analisa V. DiFeo, Norbert E. Avril · 2016 · Oncotarget
13. MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity
    Eli Grunblatt, Nan Wu, Huajia Zhang, Xiaoli Liu, Justin P. Norton, Yamini M. Ohol, Paul R. Leger, Joseph B. Hiatt, Emily Eastwood, Rhiana Thomas et al. · 2020 · Genes & Development
14. MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer
    Madeleine L. Craze, Hayley Cheung, Natasha Jewa, Nuno D M Coimbra, Daniele Soria, Rokaya El Ansari, Mohammed A. Aleskandarany, Kiu Wai Cheng, Maria Diez, Christopher C. Nolan et al. · 2017 · British Journal of Cancer
15. A MYC–GCN2–eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer
    Stefanie Schmidt, David Michael Gay, Friedrich Wilhelm Uthe, Sarah Denk, Madelon Paauwe, Niels Matthes, Markus E. Diefenbacher, Sheila Bryson, Fiona Warrander, Florian Erhard et al. · 2019 · Nature Cell Biology
16. G4-quadruplex-binding proteins: review and insights into selectivity
    V. Meier-Stephenson · 2022 · Biophysical Reviews
17. The Dysregulation of Polyamine Metabolism in Colorectal Cancer Is Associated with Overexpression of c‐Myc and C/EBPβ rather than Enterotoxigenic Bacteroides fragilis Infection
    Anastasiya V. Snezhkina, George Sergeevich Krasnov, Anastasiya V. Lipatova, А. Ф. Садритдинова, Olga L. Kardymon, Maria Fedorova, Nataliya V. Melnikova, Oleg A. Stepanov, Andrew R. Zaretsky, А. Д. Каприн et al. · 2016 · Oxidative Medicine and Cellular Longevity
18. Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene
    Demma, Mark J., Mapelli, Claudio, Sun, Angie, Bodea, Smaranda, Ruprecht, Benjamin, Javaid, Sarah, Wiswell, Derek, Muise, Eric, Chen, Shiying, Zelina, John et al. · 2019 · Molecular and Cellular Biology
19. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells
    Francis O. Enane, Yogen Saunthararajah, Murray Korc · 2018 · Cell Death and Disease
20. Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer
    Yufeng Ding, Ni Li, Baijun Dong, Wangxin Guo, Hui Wei, Qilong Chen, Huairui Yuan, Ying Han, Hanwen Chang, Shan Kan et al. · 2018 · Journal of Clinical Investigation
21. circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer
    Sen Wang, Dong Tang, Wei Wang, Yining Yang, Xiaoqing Wu, Liuhua Wang, Daorong Wang · 2019 · Molecular Cancer
22. Reactive intermediates for interactome mapping
    Ciaran P. Seath, Aaron Trowbridge, Tom W. Muir, David W. C. MacMillan · 2021 · Chemical Society Reviews
23. <i>MYC</i> Regulates the <i>HIF2α</i> Stemness Pathway via <i>Nanog</i> and <i>Sox2</i> to Maintain Self-Renewal in Cancer Stem Cells versus Non-Stem Cancer Cells
    Das, Bikul, Pal, Bidisha, Bhuyan, Rashmi, Li, Hong, Sarma, Anupam, Gayan, Sukanya, Talukdar, Joyeeta, Sandhya, Sorra, Bhuyan, Seema, Gogoi, Gayatri et al. · 2019 · Cancer Research
24. The role of pluripotency factors to drive stemness in gastrointestinal cancer
    Martin Müller, Patrick Christian Hermann, Stefan Liebau, Clair E. Weidgang, Thomas Theodor Werner Seufferlein, Alexander Kleger, Lukas Perkhofer · 2016 · Stem Cell Research
25. Machine learning integrated ensemble of feature selection methods followed by survival analysis for predicting breast cancer subtype specific miRNA biomarkers
    Jnanendra Prasad Sarkar, Indrajit Saha, Anasua Sarkar, Ujjwal Maulik · 2021 · Computers in Biology and Medicine
26. Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
    Yujie Zhao, Xu Liu, Xinyu Liu, Jing Xia Yu, Xin Bai, Xi Lawrence Wu, Xinyu Guo, Zhihui Liu, Xiaowei Liu · 2022 · Frontiers in Immunology
27. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells
    Maria Saveria Gilardini Montani, Marisa Granato, Claudio Santoni, Paola Del Porto, Nicolò Merendino, Gabriella D’Orazi, Alberto Faggioni, Mara Cirone · 2017 · Cellular Oncology
28. RNAi-Mediated Silencing of Myc Transcription Inhibits Stem-like Cell Maintenance and Tumorigenicity in Prostate Cancer
    Gianluca Civenni, Anastasia V. Malek, Domenico Albino, Ramón García‐Escudero, Sara Napoli, Stefano Di Marco, Sandra Pinton, Manuela Sarti, Giuseppina Maria Carbone, Carlo Vittorio Catapano · 2013 · Cancer Research
29. c-Myc and viral cofactor Kaposin B co-operate to elicit angiogenesis through modulating miRNome traits of endothelial cells
    Hsin-Chuan Chang, Tsung‐Han Hsieh, Yi-Wei Lee, Cheng-Fong Tsai, Ya-Ni Tsai, Cheng-Chung Cheng, Hsei–Wei Wang · 2016 · BMC Systems Biology
30. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
    Audrey Bouillez, Hasan N. Rajabi, Sean P. Pitroda, Caining Jin, Maroof Alam, Akriti Kharbanda, Ashujit Tagde, Kwok‐Kin Wong, Donald W. Kufe · 2016 · Cancer Research
31. The Interconnections between Autophagy and Integrin-Mediated Cell Adhesion
    Ariadne Vlahakis, Jayanta Debnath · 2016 · Journal of Molecular Biology
32. Metabolic plasticity drives development during mammalian embryogenesis
    Mark S. Sharpley, Fangtao Chi, Johanna ten Hoeve, Utpal K. Banerjee · 2021 · Developmental Cell
33. Beyond controlling cell size: functional analyses of S6K in tumorigenesis
    Xueji Wu, Wei Xie, Wen-Xuan Xie, Wen-Yi Wei, Jian-ping Guo · 2022 · Cell Death and Disease
34. CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expression
    Steven Christopher Smith, Darya G. Buehler, Eun-Young Karen Choi, Jonathan Brad McHugh, Brian P. Rubin, Steven D. Billings, Bonnie Lei Balzer, Dafydd G. Thomas, David Robert Lucas, John R. Goldblum et al. · 2014 · Modern Pathology
35. Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy
    Yuan Zhang, Lei Peng, Russell J. Mumper, Leaf Huang · 2013 · Biomaterials
36. Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer
    Pek, M, Yatim, S M J M, Chen, Y, Li, J, Gong, M, Jiang, X, Zhang, F, Zheng, J, Wu, X, Yu, Q · 2017 · Oncogene
37. MYC Modulation around the CDK2/p27/SKP2 Axis
    Per Hydbring, Alina Castell, Lars‐Gunnar Larsson · 2017 · Genes
38. N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development
    Yi Niu, Arabella H. Wan, Ziyou Lin, Xiongbin Lu, Guohui Wan · 2018 · Acta Pharmaceutica Sinica B
39. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells
    Kenly Wuputra, Chia‐Chen Ku, Deng‐Chyang Wu, Ying‐Chu Lin, Shigeo Saito, Kazunari K. Yokoyama · 2020 · Journal of Experimental & Clinical Cancer Research
40. Molecular Crosstalk Between MYC and HIF in Cancer
    Yanping Li, Xiao‐Xin Sun, David Z. Qian, Mu‐Shui Dai · 2020 · Frontiers in Cell and Developmental Biology
41. MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma
    Ganna Oliynyk, María Victoria Ruiz-Pérez, Lourdes Sainero‐Alcolado, Johanna Dzieran, Hanna Zirath, Héctor Gallart‐Ayala, Craig Edward Wheelock, Henrik J. Johansson, Roland Nilsson, Janne Lehtiö et al. · 2019 · iScience
42. Homeostasis and transitional activation of regulatory T cells require c-Myc
    Jordy Saravia, Hu Zeng, Yogesh Dhungana, Daniel Bastardo Blanco, Thanh-Long M. Nguyen, Nicole M. Chapman, Yanyan Wang, Apurva Kanneganti, Shaofeng Liu, Jana L. Raynor et al. · 2020 · Science Advances
43. HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
    Harada, T, Ohguchi, H, Grondin, Y, Kikuchi, S, Sagawa, M, Tai, Y-T, Mazitschek, R, Hideshima, T, Anderson, K C · 2017 · Leukemia
44. MYC and DNMT 3A‐mediated DNA methylation represses micro RNA ‐200b in triple negative breast cancer
    Yamei Pang, Jian Liu, Li Xiang, Guodong Xiao, Huangzhen Wang, Ganghua Yang, Yanbo Li, Shou‐Ching Tang, Sida Qin, Ning Du et al. · 2018 · Journal of Cellular and Molecular Medicine
45. Ins and outs of cadmium-induced carcinogenesis: Mechanism and prevention
    Zheng‐Guo Cui, Kanwal Ahmed, Syed Faisal Zaidi, Jibran Sualeh Muhammad · 2021 · Cancer Treatment and Research Communications
46. Regulation of cancer stem cells in triple negative breast cancer
    Norman Fultang, Madhuparna Chakraborty, Bela Peethambaran · 2021 · Cancer Drug Resistance
47. Antagonism between FOXO and MYC Regulates Cellular Powerhouse
    Barrie Peck, Emma C. Ferber, Almut Schulze · 2013 · Frontiers in Oncology
48. Amplitude modulation of androgen signaling by c-MYC
    Min Ni, Yiwen Chen, Teng Fei, Dan Li, Elgene Lim, X. Shirley Liu, Myles A Brown · 2013 · Genes & Development
49. Recent advances in anti-angiogenic nanomedicines for cancer therapy
    Pravin Bhattarai, Sadaf Hameed, Zhifei Dai · 2018 · Nanoscale
50. Drugging “undruggable” genes for cancer treatment: Are we making progress?
    Michael Joe Duffy, John Paul Crown · 2020 · International Journal of Cancer
51. Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control
    Peng Dong, Manoj V. Maddali, Jaydeep K. Srimani, François A. Thélot, Joseph Roy Nevins, Bernard Mathey-Prévôt, Lingchong You · 2014 · Nature Communications
52. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia
    Bing Xia, Chen Tian, Shanqi Guo, Le Zhang, Dandan Zhao, Fulian Qu, Weipeng Zhao, Yafei Wang, Xiaoxiong Wu, Wan-Ming Da et al. · 2014 · Leukemia Research
53. Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
    Steffen Grampp, James L. Platt, Victoria Lauer, Rafik A. Salama, Franziska Kranz, Viviana K. Neumann, Sven Wach, Christine Stöhr, Arndt Hartmann, Kai‐Uwe Eckardt et al. · 2016 · Nature Communications
54. Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes
    Saeed Hassani, Parisa Ghaffari, Bahram Chahardouli, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Shaban Alizadeh, Seyed Hamidollah Ghaffari · 2018 · Biomedicine & Pharmacotherapy
55. Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis
    Chenfeng Wang, Yang Yang, Guang Chun Zhang, Jingxin Li, Xianning Wu, Xiaoling Ma, Ge Shan, Yide Mei · 2019 · Proceedings of the National Academy of Sciences
56. AMPK and HIF signaling pathways regulate both longevity and cancer growth: the good news and the bad news about survival mechanisms
    Antero Salminen, Kai Kaarniranta, Anu Kauppinen · 2016 · Biogerontology
57. Silibinin induces metabolic crisis in triple‐negative breast cancer cells by modulating EGFR‐MYC‐TXNIP axis: potential therapeutic implications
    Mohammad Askandar Iqbal, Shilpi Chattopadhyay, Farid Ahmad Siddiqui, Asad Ur Rehman, Shumaila Iqbal Siddiqui, Gopinath Prakasam, Asifa Khan, Sarwat Sultana, Ramesh N K Bamezai · 2020 · FEBS Journal
58. A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer
    Vetriselvan Subramaniyan, Shivkanya Fuloria, Gaurav Gupta, Darnal Hari Kumar, Mahendran Sekar, Kathiresan V. Sathasivam, Kalvatala Sudhakar, Khalid Saad Alharbi, Waleed Hassan Almalki, Obaid Afzal et al. · 2021 · Chemico-Biological Interactions
59. Surface-Enhanced Raman Scattering Surface Selection Rules for the Proteomic Liquid Biopsy in Real Samples: Efficient Detection of the Oncoprotein c-MYC
    Elena Pazos, Manuel García‐Algar, Cristina Penas, Moritz Nazarenus, Arnau Torruella, Nicolas Pazos Pérez, Luca Guerrini, M. Eugenio Vázquez, Eduardo García‐Rico, Jose Luis Mascarenas et al. · 2016 · Journal of the American Chemical Society
60. c-Myc–miR-29c–REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma
    Hui Luo, Zhengxin Chen, Shuai Wang, Rui Zhang, Wenjin Qiu, Lin Zhao, Chenghao Peng, Ran Xu, Wanghao Chen, Hongwei Wang et al. · 2015 · Brain
61. c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease
    Zheng, Kang, Cubero, Francisco, Nevzorova, Yulia · 2017 · Genes
62. The master regulator FUBP1: its emerging role in normal cell function and malignant development
    Lydie Debaize, Marie‐Bérengère Troadec · 2018 · Cellular and Molecular Life Sciences
63. Sequence specificity incompletely defines the genome-wide occupancy of Myc
    Jiannan Guo, Tiandao Li, J.L. Schipper, Kyle A. Nilson, Francis K. Fordjour, Jeffrey J. Cooper, Raluca Gordân, David H. Price · 2014 · Genome biology
64. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer
    Ayesha N. Shajahan‐Haq, Katherine Loree Cook, Jessica L. Schwartz‐Roberts, Ahreej E. Eltayeb, Diane M. Demas, Anni M. Wärri, Caroline O. B. Facey, Leena A Hilakivi-Clarke, Robert C. Clarke · 2014 · Molecular Cancer
65. Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
    Edina Wang, Anabel Sorolla, Paula T. Cunningham, Heique Marlis Bogdawa, Samuel J. Beck, Emily Golden, Robert E. Dewhurst, Laura Florez, Mark N. Cruickshank, Katrin Hoffmann et al. · 2018 · Oncogene
66. BET Protein Inhibitor JQ1 Attenuates Myc-Amplified MCC Tumor Growth In Vivo
    Qiang Shao, Aarthi Kannan, Zhenyu Lin, Brendan C. Stack, James Y. Suen, Ling Gao · 2014 · Cancer Research
67. The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity
    Baohan Thi Vo, Elmar Wolf, Daisuke Kawauchi, Anneli Gebhardt, Jerold E. Rehg, David Finkelstein, Susanne Walz, Brian L. Murphy, Yong Ha Youn, Young-Goo Han et al. · 2016 · Cancer Cell
68. Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
    Jared R. Mayers, Matthew G. Vander Heiden · 2017 · Cancer Research
69. Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF
    Aram Ko, Su Yeon Han, Chel Hun Choi, Hanbyoul Cho, Min-Sik Lee, Soo‐Youl Kim, Joon Seon Song, Kyeong‐Man Hong, Han‐Woong Lee, Stephen M. Hewitt et al. · 2018 · Cell Death and Differentiation
70. Imp/IGF2BP levels modulate individual neural stem cell growth and division through myc mRNA stability
    Tamsin J. Samuels, Aino I. Järvelin, David Ish‐Horowicz, Ilan Davis · 2020 · eLife
71. Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy
    Davis, Leah, Recktenwald, Matthias, Hutt, Evan, Fuller, Schuyler, Briggs, Madison, Goel, Arnav, Daringer, Nichole · 2022 · Cancers
72. Origin and Therapies of Osteosarcoma
    Brice Moukengué, Morgane Lallier, Louise Marchandet, Marc Baud’huin, Franck Verrecchia, Benjamin Ory, François Lamoureux · 2022 · Cancers
73. MYC regulates the non-coding transcriptome
    Jonathan Ross Hart, Thomas C. Roberts, Marc S. Weinberg, Kevin V. Morris, Peter K. Vogt · 2014 · Oncotarget
74. A Metabolism Toolbox for CAR T Therapy
    Xuequn Xu, JN Rashida Gnanaprakasam, John William Sherman, Ruoning Wang · 2019 · Frontiers in Oncology
75. MicroRNAs and Cancer: A Long Story for Short RNAs
    Alessandra Drusco, Carlo Maria Croce · 2017 · Advances in cancer research
76. The Dual Roles of the Atypical Protein Kinase Cs in Cancer
    Miguel Reina‐Campos, Maria Teresa Díaz-Meco, Jorge Moscat · 2019 · Cancer Cell
77. Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?
    Zhongqi Bu, Haiyang Yu, Jue Wang, Xin He, Yueran Cui, Jiachun Feng, Juan Feng · 2021 · ASN NEURO
78. Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma
    Qian Hu, Lingli Li, Xin Zou, Lijun Xu, Ping Yi · 2018 · Frontiers in Pharmacology
79. Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
    Anthony Chan, Chun-Wei David Chen · 2019 · Frontiers in Cell and Developmental Biology
80. Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming
    Bernadette M. M. Zwaans, David B. Lombard · 2014 · Disease Models & Mechanisms
81. The Role of Histone Demethylase KDM4B in Myc Signaling in Neuroblastoma
    Jun J.J. Yang, Alaa M. AlTahan, Dongli Hu, Yingdi Wang, Pei-Hsin Cheng, Christopher L. Morton, Chunxu Qu, Amit Chunilal Nathwani, Jason Matthew Shohet, Theodore Fotsis et al. · 2015 · JNCI Journal of the National Cancer Institute
82. Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas
    An Na Seo, Jun Mo Yang, H Kim, Sanghoon Jheon, K Kim, Lee Ct, Y Jin, S Yun, J-H Chung, Jin Ho Paik · 2014 · British Journal of Cancer
83. Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development
    Je Yeong Ko, Sumin Oh, Kyung Hyun Yoo · 2017 · Molecules and Cells
84. Coordinated transcriptional and catabolic programs support iron-dependent adaptation to RAS-MAPK pathway inhibition in pancreatic cancer
    Ravichandran, Mirunalini, Hu, Jingjie, Cai, Charles, Ward, Nathan P., Venida, Anthony, Foakes, Callum, Kuljanin, Miljan, Yang, Annan, Hennessey, Connor J., Yang, Yang et al. · 2022 · Cancer Discovery
85. microRNA Control of Mouse and Human Pluripotent Stem Cell Behavior
    Thomas Greve, Robert L. Judson, Robert H. Blelloch · 2013 · Annual Review of Cell and Developmental Biology
86. Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth
    Marilyn Mathew, Nhi Thi Hong Nguyen, Yangzom Doma Bhutia, Sathish Sivaprakasam, Vadivel Ganapathy · 2024 · Cancers
87. Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma
    Allen-Petersen, Brittany L., Risom, Tyler, Feng, Zipei, Wang, Zhiping, Jenny, Zina P., Thoma, Mary C., Pelz, Katherine R., Morton, Jennifer P., Sansom, Owen J., Lopez, Charles D. et al. · 2019 · Cancer Research
88. Cancer: pathological nuclear reprogramming?
    Colin R. Goding, Duanqing Pei, Xin Lü · 2014 · Nature reviews. Cancer
89. Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer
    Guofeng Ma, Ye Liang, Yuanbin Chen, Liping Wang, Dan Li, Zhijuan Liang, Xiao Wang, Dongxu Tian, Xuecheng Yang, Haitao Niu · 2019 · Molecular Cancer Research
90. L-Myc expression by dendritic cells is required for optimal T-cell priming
    Wumesh KC, Ansuman T. Satpathy, Aaron S. Rapaport, Carlos G. Briseño, Xiaodi Wu, Jörn C. Albring, Emilie V. Russler-Germain, Nicole M. Kretzer, Vivek Durai, Stephen P. Persaud et al. · 2014 · Nature
91. MYC Drives Pten/Trp53 -Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2
    Dawid Grzegorz Nowak, Hyejin Cho, Tali M. Herzka, Kaitlin E. Watrud, Daniel V. DeMarco, Victoria M.-Y. Wang, Şerif Şentürk, Christof Fellmann, David Ding, Tumas Beinortas et al. · 2015 · Cancer Discovery
92. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification
    German Ott, Andreas Rosenwald, Elı́as Campo · 2013 · Hematology
93. Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan
    Anna Francina Jackson, Andrew Williams, Leslie Recio, Michael D. Waters, Iain B. Lambert, Carole Lyn Yauk · 2013 · Toxicology and Applied Pharmacology
94. MicroRNA-451 induces epithelial–mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc
    Dongqin Chen, Jiayuan Huang, Kai Zhang, Banzhou Pan, Jing Chen, Wei De, Rui Wang, Longbang Chen · 2014 · European Journal of Cancer
95. The potential of multi-compound nanoparticles to bypass drug resistance in cancer
    Candido G. Da Silva, Godefridus J. Peters, FERRY A. OSSENDORP, Luis Javier Cruz · 2017 · Cancer Chemotherapy and Pharmacology
96. Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence
    Ben Sang, Yuan Yuan Zhang, Su Guo, Ling Fei Kong, Qiong Cheng, Guangzhi Liu, Rick Francis Thorne, Xu Dong Zhang, Lei Jin, Mian Wu · 2018 · Proceedings of the National Academy of Sciences
97. Calcium Homeostasis Disruption - a Bridge Connecting Cadmium-Induced Apoptosis, Autophagy and Tumorigenesis
    Xuehai Zhou, Weiming Hao, Haifeng Shi, Yongzhong Hou, Qinggang Xu · 2015 · Oncology Research and Treatment
98. Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
    Zachary R. Crook, Gregory P. Sevilla, Della J. Friend, Mi‐Youn Brusniak, Ashok D. Bandaranayake, Midori Clarke, Mesfin M. Gewe, Andrew J. Mhyre, David A. Baker, Roland K. Strong et al. · 2017 · Nature Communications
99. A Time for MYC: Metabolism and Therapy
    Chi Van Dang · 2016 · Cold Spring Harbor Symposia on Quantitative Biology
100. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma
     Jiayuan Huang, Kai Zhang, Dongqin Chen, Jing Chen, Bing Feng, Haizhu Song, Yitian Chen, Ziman Zhu, Lei Lü, Wei De et al. · 2015 · Oncotarget